Amalia M. Issa PhD
Amalia M. Issa PhD
Chair, Department of Health Policy and Public Health
Professor of Health Policy and Public Health
Personalized Medicine; pharmacogenomics; pharmaceutical outcomes research and policy; pharmacoepidemiology
Dr. Amalia M. Issa is Professor of Health Policy and Public Health and Chair of the Department of Health Policy and Public Health and the Director of the Program in Personalized Medicine and Targeted Therapeutics. The Program was founded in 2001, by Dr. Issa, as one of the first centers focused on pharmacogenomics and personalized medicine to advance the science and translation of personalized medicine through state-of-the-art research and education. Dr. Issa has developed a unique area of translational research focused on pharmacogenomics and personalized medicine applications, and how they will be translated and integrated into health care delivery and health systems. Her research is positioned at the nexus of epidemiology/health services research and molecular science, and she leads an interdisciplinary team of scientists who are actively engaged in research aimed at the effective translation of the science of pharmacogenomics and personalized medicine from the laboratory bench to the bedside and to the community and policy. Dr. Issa and her team are committed to developing the evidence base for, promoting informed decision making about, and accelerating knowledge translation of personalized medicine applications into meaningful health outcomes. Dr. Issa is nationally and internationally recognized in the field of personalized medicine, and has published numerous papers, many widely cited, in pharmacogenomics and personalized medicine, clinical pharmacology, neuropharmacology and drug safety. She has served or is serving as the principal investigator on a number of funded projects, and is a reviewer for several scientific journals, granting agencies. Dr. Issa serves on editorial boards and in leadership positions in several professional associations, and has received many awards and honors for her work.
Selected Scholarly Activity
Issa, AM, Hutchinson JF, Tufail W, Fletcher E, Ajike R, and Tenorio J. Provision of Personalized Genomic Diagnostic Technologies for Breast and Colorectal Cancer: An Analysis of Patient Needs, Expectations and Priorities Personalized Medicine 8(4): 401-411, 2011.
Joly Y., Koutrikas G., Tassé AM., Issa AM., Carleton B., Hayden M., Rieder MJ.,Ramos- Paque E. and Avard D. Regulatory approval for new pharmacogenomics tests: A comparative overview. Food and Drug Law Journal 66 (1): 1-24, 2011.
Arar, N., Knight SJ, Modell SM and Issa, AM. The Genome-based knowledge management in cycles (G-KNOMIC) model: A complex adaptive systems framework for implementation of genomic applications. Pers. Med. 8(2): 191-205, 2011.
McKibben L, Boone DJ , Marchibroda J and. Issa AM, A novel transformation model for personalized medicine laboratory systems Pers. Med, 7(1): 87-94, 2010.
Issa, AM, Tufail, W. Hutchinson, JF,Tenorio J, Baliga MP. Assessing patient readiness for the clinical adoption of personalized medicine. Public Health Genomics, 12: 163-169, 2009
Issa, AM., Evaluating the value of genomic diagnostics: Implications for clinical practice and public policy. Adv. Health Econ. Health Services Research 19, 191-206, 2008.
Issa, AM. Clinical applications of pharmacogenomics to adverse drug reactions. Expert Clin. Pharmacol. 1(2), 251–260, 2008.
Issa, AM, Phillips KA, Van Bebber S, Nidamarthy HG, Lasser KE, Haas JS, Alldredge BK, Wachter RM, and Bates DW. Drug withdrawals in the United States: A systematic review of the evidence and analysis of trends. Current Drug Safety, 2 (3):177-185, 2007.
|Office location:||4101 Woodland Avenue Room 127|
|Mailing address:||Box 22|
University of Sciences
600 South 43rd Street
Philadelphia, PA 19104-4495
a [dot] issa [at] usciences [dot] edu